Cost-effectiveness of three years of adjuvant imatinib in gastrointestinal stromal tumors (GIST).
Myrlene Sanon
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Anju Parthan
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Douglas Taylor
Consultant or Advisory Role - Novartis
Research Funding - Novartis
John Coombs
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Marc Paolantonio
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Medha Sasane
Employment or Leadership Position - Novartis
Stock Ownership - Novartis